Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR52H1 Inhibitors

OR52H1 inhibitors represent a specialized class of chemical compounds designed to modulate the function of the OR52H1 protein, which is part of the olfactory receptor family. These receptors, embedded in the cell membranes, play a key role in detecting odorants by binding specific molecules and initiating a signal transduction pathway that results in olfactory perception. OR52H1, like other olfactory receptors, is a G-protein-coupled receptor (GPCR), which undergoes conformational changes upon ligand binding. The inhibition of OR52H1 can prevent or modulate this signal transduction, thereby altering the receptor's response to its target ligands. The molecular mechanisms through which OR52H1 inhibitors act generally involve binding to the receptor's active site or to allosteric regions, preventing either the binding of the natural ligand or the subsequent conformational shifts required for signal propagation.

In terms of chemical structure, OR52H1 inhibitors can vary greatly, depending on the molecular design required to achieve high specificity and affinity for the receptor. Many inhibitors are small organic molecules, often tailored to fit the binding pocket of OR52H1, mimicking the size, shape, or charge distribution of its natural ligands. Some inhibitors may operate through covalent binding, while others may employ non-covalent interactions like hydrogen bonding, hydrophobic interactions, or van der Waals forces to stabilize their interaction with the receptor. The study of these inhibitors contributes to a deeper understanding of receptor-ligand interactions and signal transduction mechanisms, particularly within the GPCR family, which represents a vast and functionally diverse class of proteins. The modulation of olfactory receptor activity through inhibition provides insight into broader principles of GPCR regulation and potential applications in molecular biology and biochemistry.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002, as a PI3K inhibitor, may reduce the transcription of OR52H1 by altering the phosphorylation status of proteins involved in the signaling cascade that controls OR52H1 expression levels.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium Butyrate, through its HDAC inhibitory activity, could increase histone acetylation near the OR52H1 gene, leading to a tightly packed chromatin state and consequent silencing of OR52H1 gene transcription.